TELL ME MORE
ABOUT THIS CLINICAL TRIAL for COMMON WARTS IN CHILDREN AND ADULTS
This is an Efficacy, Safety and Tolerability Study of an Investigational Topical Medicine for Common Warts in Patients Ages 2 Years or More

Clinical Trial for Common Warts in Children and Adults
Study Location(s): Evansville Indiana
Warts are non-cancerous (benign) skin growths that develop on different parts of the body and come in various forms. They are caused by viruses. Warts are contagious and very common: Most people will have one at some point in their lives. Although they can affect people at any age, warts are most common among children and teenagers. This is an efficaccy, safety and tolerability study to evaluated an investigational topical medicine for commone wasts in children and adults. Click here for more information on diagnosing and treating warts.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimburrsement up to $400 may be available.
View More Studies
Condition | Location | Status | Age Range | Sex | Max Compensation | |
---|---|---|---|---|---|---|
ADHD A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication | Bowling Green Owensboro | Enrolling | 6 - 17 | $1150 | Request Info | |
COPD A Phase 3 Study to Evaluate the Efficacy and Safety of Two Dose Regimens of an Investigational Medication in Participants with Symptomatic COPD | Bowling Green | Enrolling | 40+ | Up to $1200 | Request Info | |
COPD Safety, Efficacy and Tolerance study for moderate to severe COPD | Owensboro | Enrolling | 40-85 | Up to $750 | Request Info | |
DIABETES (T2DM) Safety and Efficacy of an Investigational Medicine for pediatric and adolescent patients with type 2 diabetes. | Evansville | Enrolling | 10-17 | Up to $875 | Request Info | |
DIABETES (T2DM) Study to Evaluate the Efficacy and Safety of an Investigation Medication as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults with Type 2 Diabetes | Bowling Green Evansville Owensboro | Coming Soon | 18 Years & Up | $1625 | Request Info | |
ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study of a topical investigational medicine with open-label extension in patients with moderate to severe eczema | Owensboro | Enrolling | 2+ (child through adult) | $490 | Request Info | |
ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study of a topical investigational medicine with open-label extension in patients with moderate to severe eczema | Evansville | Enrolling | 2+ (child through adult) | $560 - $1400 | Request Info | |
INFANT FORMULA & BREASTFEEDING Infant Formula for Healthy Babies | Evansville Owensboro | Enrolling | Newborns | $625 + formula | Request Info | |
LUPUS (SLE) A Randomized, Placebo-Controlled Clinical Trial for the Treatment of Systemic Lupus Erythematosus | Evansville | Enrolling | 18 - 65 | $800 | Request Info | |
LUPUS NEPHRITIS A Safety, efficacy and tolerability study for patients with active Lupus Nephritis | Evansville | Enrolling | 18 - 75 | $4625 ($125 per visit) | Request Info | |
MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Enrolling | 6 - 17 | $200/$350 | Request Info | |
MENINGOCOCCAL VACCINE Safety and Immunogenicity of a Meningococcal B vaccine when Administered Together with the MENVEO (MenACWY) Vaccine in healthy subjects age 16 - 18 | Evansville | Enrolling | 16-18 | $300 | Request Info | |
PSORIASIS A Double-blind, Placebo-controlled Study to Investigate the Efficacy of an Investigational Oral Medication of Moderate to Severe Plaque Psoriasis | Owensboro Evansville | Enrolling | 18-75 | Up to $585 | Request Info | |